David A. Melnick - Net Worth and Insider Trading

David A. Melnick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A. Melnick owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .

Click here to see the complete history of David A. Melnick’s form 4 insider trades.

Insider Ownership Summary of David A. Melnick

Ticker	Comapny	Transaction Date	Type of Owner
SPRO	Spero Therapeutics Inc	2018-01-04	Chief Medical Officer

David A. Melnick Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A. Melnick Ownership Network

Ownership Network List of David A. Melnick

No Data

Ownership Network Relation of David A. Melnick

David A. Melnick Owned Company Details

What does Spero Therapeutics Inc do?

Who are the key executives at Spero Therapeutics Inc?

David A. Melnick is the Chief Medical Officer of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , director & See Remarks Ankit Mahadevia , and Chief Financial Officer Sath Shukla .

Spero Therapeutics Inc (SPRO) Insider Trades Summary

Over the past 18 months, David A. Melnick made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 10,882 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 10,882 shares. During the past 18 months, 331,325 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 331,325 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spero Therapeutics Inc Insider Transactions

No Available Data

David A. Melnick Mailing Address

Above is the net worth, insider trading, and ownership report for David A. Melnick. You might contact David A. Melnick via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Ave., 14th Floor, Cambridge Ma 02139.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.